PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia · Delayed Price · Currency is IDR 336.00
+2.00 (0.60%)
At close: Apr 9, 2026
IDX:OBAT Revenue
PT Brigit Biofarmaka Technologi Tbk had revenue of 38.18B IDR in the quarter ending September 30, 2025, with 10.03% growth. This brings the company's revenue in the last twelve months to 145.91B, up 34.73% year-over-year. In the year 2024, PT Brigit Biofarmaka Technologi Tbk had annual revenue of 120.63B with 111.89% growth.
Revenue (ttm)
145.91B
Revenue Growth
+34.73%
P/S Ratio
1.38
Revenue / Employee
8.58B
Employees
17
Market Cap
201.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120.63B | 63.70B | 111.89% |
| Dec 31, 2023 | 56.93B | 18.43B | 47.89% |
| Dec 31, 2022 | 38.50B | 642.48M | 1.70% |
| Dec 31, 2021 | 37.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition